SHAILESH SIROYA's Insider Trades & SAST Disclosures
SHAILESH SIROYA's most recent trade in Bal Pharma Ltd. was a Acquisition of 650,000 Equity Shares done at an average price of Rs. 50 . Disclosure was reported to the exchange on March 22, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
SHAILESH SIROYA's has made SAST transactions in Bal Pharma Ltd. recently where a Acquisition of 750,000 shares done . Disclosure was reported to the exchange on April 13, 2022.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bal Pharma | Shailesh Siroya | Promoter | Acquisition | 13 Apr 2022 | 750,000 | 2,745,459 (17.63%) | 4.82% | - | 13 Apr 2022 13 Apr 2022 |
SAST (29(2)) | - | Pref. Allotment | |
| Bal Pharma | SHAILESH SIROYA | Promoter | Acquisition | 22 Mar 2021 | 650,000 | 1,995,459 (13.46%) | 4.59% | 50 | 32,500,000 | 17 Mar 2021 17 Mar 2021 |
Insider Trading | Equity Shares | Conversion of security |
| Bal Pharma | Shailesh Siroya | Promoter | Acquisition | 23 Mar 2021 | 650,000 | 1,995,459 (13.46%) | 4.38% | - | 17 Mar 2021 17 Mar 2021 |
SAST (29(2)) | - | Allotment |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.